FDA gives first approval for recurrent respiratory papillomatosis therapy
This is the second therapy available, expanding options beyond surgery and the limited use of interferon marketed in Russia.
Healthcare
Sartorius to invest $3m for minority share in biotech start-up Nanotein
African countries plan shift to healthcare funding autonomy amid aid cuts
Can rare disease research in the US thrive under the new administration?
Ultragenyx receives complete response letter for UX111 BLA
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
DoH and Children’s National Hospital link for cell and gene therapy
Teva to collaborate with Fosun Pharma for TEV-56278
